What is your cochlear dose constraint when treating acoustic neuromas with SRS in a patient with intact hearing?
Would you ever de-escalate your prescription dose in order to reduce cochlear dose when treating younger patients with intact hearing?
Answer from: Radiation Oncologist at Academic Institution
The critical components of hearing susceptible to radiation toxicity of vestibular schwannoma treatment include acoustic nerve, cochlea, and brain stem. It is unclear which structure is responsible. It helps to understand the continuum of fibers from the endolymphatic receptors from cochlea to form ...
Comments
Radiation Oncologist at Radiant Oncology Dr. @Samuel Ryu, what do you limit the cochlea to ...
Dr. @Samuel Ryu, what do you limit the cochlea to ...